search
Back to results

I HEAL for Breast Cancer Survivors With Diabetes (I HEAL)

Primary Purpose

Diabetes

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Diabetes Coping Skills Training (DCST)
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes focused on measuring Coping Skills Training, Diabetes Education

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • diagnosis of Stage I to III breast cancer,
  • diagnosis of diabetes mellitus type 2
  • completed local definitive treatment (i.e., surgical treatment, chemotherapy and/or radiation therapy),
  • physician verification of ability to participate in the intervention,
  • English speaking.

Exclusion Criteria:

  • <21 years of age,
  • severe cognitive or hearing impairment,
  • unable to provide meaningful consent (i.e., impairment such that descriptions of the research are not clearly understood),
  • presence of a health problem that precludes safe participation in the intervention.

Sites / Locations

  • Duke University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Diabetes Coping Skills training (DCST)

Diabetes Education

Arm Description

Twelve sessions are delivered over 6 months using a faded contact model involving 6 weekly sessions, 3 biweekly sessions and 3 monthly sessions.

one 60 minute diabetes education session.

Outcomes

Primary Outcome Measures

Change in physical symptoms
The Checklist measures the severity of different symptoms (e.g., pain, fatigue, numbness and tingling) associated with illness and disease.
Change in psychological distress
The eight-item Patient Reported Outcomes Information System (PROMIS).
Change in psychological distress
Anxiety will be assessed using the seven-item GAD-7 Scale.

Secondary Outcome Measures

Accessing change in Diabetes self-management behaviors via self reported medication adherence
Participants who receive DCST will exhibit greater improvements in medication adherence compare to the education group.
Accessing change in Diabetes self-management behavior via Barriers to taking medication
Participants who receive DCST will exhibit greater improvements in medication adherence compare to the education group.
Accessing change in Diabetes self-management behavior via Adherence to diabetes self-management behaviors
Participants who receive DCST will exhibit greater improvements in physical activity, dietary patterns, medication adherence, and adherence to blood glucose monitoring compare to the education group.
Accessing change in Diabetes self-management behavior via Use of home blood glucose monitoring
Participants who receive DCST will exhibit greater improvements in adherence to blood glucose monitoring compare to the education group.
Improved glycemic control
Participants who receive DCST will show greater improvements in HbA1c compared to the diabetes education alone.
Change in self-efficacy
This contains 5 items that inquire about patients' certainty about degree of pain control, pain during daily activities, controlling pain during sleep, and making pain reductions without extra medication.
Change in Physical Activity
Patient-reported physical activity will be assessed using the well-validated Community Healthy Activities Model Program for Seniors (CHAMPS). Participants who receive DCST will show improved self efficacy for managing symptoms and diabetes self-management compared to the diabetes education alone.
Assessing change in Physical Activity
Wireless activity tracking devices will be used to assess daily steps and distance. Participants who receive DCST will show improved self efficacy for managing symptoms and diabetes self-management compared to the diabetes education alone.

Full Information

First Posted
October 21, 2016
Last Updated
February 28, 2022
Sponsor
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT02970344
Brief Title
I HEAL for Breast Cancer Survivors With Diabetes
Acronym
I HEAL
Official Title
Improving Health Engagement and Lifestyle Management for Breast Cancer Survivors With Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
April 20, 2017 (Actual)
Primary Completion Date
December 1, 2021 (Actual)
Study Completion Date
December 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The proposed randomized clinical trial evaluates a diabetes coping skills training (DCST) intervention for improving breast cancer survivors' abilities to manage symptoms and adhere to recommended diabetes self-management. The telephone-based DCST protocol integrates three key strategies to reduce symptoms and improve diabetes self-management: coping skills training for managing symptoms, adherence skills training, and healthy lifestyle skills training. The investigator will test the effects of the DCST intervention by comparing it to diabetes education alone. Physical symptoms, psychological distress, diabetes self-management behaviors, and self-efficacy for managing symptoms and diabetes self-management will be assessed at baseline and 3, 6, and 12 months. Physical activity (i.e., daily steps and distance) will be assessed using wireless activity trackers and data will be obtained from home blood glucose monitoring devices. Glycosylated hemoglobin (HbA1c) will be assessed at baseline, 6, and 12 months.
Detailed Description
Together, breast cancer and type 2 diabetes represent a public health crisis. Approximately 20% of the 3.1 million breast cancer survivors in the U.S. have type 2 diabetes, and this number is expected to grow. Breast cancer survivors who have type 2 diabetes are at high risk for cancer recurrence, serious health complications, and premature death. Breast cancer survivors with type 2 diabetes experience more severe, disabling symptoms and psychological distress relative to breast cancer survivors without diabetes. For breast cancer survivors with type 2 diabetes, maintaining glycemic control is critical for decreasing symptoms and preventing serious health problems. Important diabetes self-management strategies include physical activity, dietary modifications, medication, and blood glucose monitoring. Many breast cancer survivors with type 2 diabetes have difficulty maintaining these behaviors and achieving glycemic control. Physical symptoms and psychological distress are often barriers to engaging in diabetes self-management. The proposed study evaluates a novel diabetes coping skills training (DCST) intervention for improving breast cancer survivors' abilities to manage symptoms and adhere to recommended diabetes self-management. The telephone-based DCST protocol is based on our prior work and integrates three key theory-based strategies: coping skills training for managing symptoms, adherence skills training, and healthy lifestyle skills training. The proposed randomized clinical trial (N=230) will test the effects of the DCST intervention by comparing it to diabetes education alone. Physical symptoms, psychological distress, diabetes self-management behaviors, and self-efficacy will be assessed at baseline and 3, 6, and 12 months. Physical activity will be assessed using wireless activity trackers and data will be obtained from home blood glucose monitoring devices. Glycosylated hemoglobin (HbA1c) will be assessed at baseline, 6, and 12 months. The proposed study addresses a critical gap in the care of breast cancer survivors by evaluating a novel behavioral intervention that aims to improve the management of symptoms, adherence, and glycemic control in breast cancer survivors with type 2 diabetes. The findings of this study could lead to significant improvements in clinical care and beneficial outcomes for breast cancer survivors.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes
Keywords
Coping Skills Training, Diabetes Education

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diabetes Coping Skills training (DCST)
Arm Type
Experimental
Arm Description
Twelve sessions are delivered over 6 months using a faded contact model involving 6 weekly sessions, 3 biweekly sessions and 3 monthly sessions.
Arm Title
Diabetes Education
Arm Type
No Intervention
Arm Description
one 60 minute diabetes education session.
Intervention Type
Behavioral
Intervention Name(s)
Diabetes Coping Skills Training (DCST)
Intervention Description
Diabetes Coping Skills Training (DCST) consist of twelve 50 minutes sessions delivered over 6 months using a faded contact model ( 6 weekly session, 3 biweekly sessions and 3 monthly sessions)
Primary Outcome Measure Information:
Title
Change in physical symptoms
Description
The Checklist measures the severity of different symptoms (e.g., pain, fatigue, numbness and tingling) associated with illness and disease.
Time Frame
baseline, 3 months, 6 months and 12 months
Title
Change in psychological distress
Description
The eight-item Patient Reported Outcomes Information System (PROMIS).
Time Frame
baseline, 3 months, 6 months and 12 months
Title
Change in psychological distress
Description
Anxiety will be assessed using the seven-item GAD-7 Scale.
Time Frame
baseline, 3 months, 6 months and 12 months
Secondary Outcome Measure Information:
Title
Accessing change in Diabetes self-management behaviors via self reported medication adherence
Description
Participants who receive DCST will exhibit greater improvements in medication adherence compare to the education group.
Time Frame
Baseline to 12 months
Title
Accessing change in Diabetes self-management behavior via Barriers to taking medication
Description
Participants who receive DCST will exhibit greater improvements in medication adherence compare to the education group.
Time Frame
Baseline to 12 months
Title
Accessing change in Diabetes self-management behavior via Adherence to diabetes self-management behaviors
Description
Participants who receive DCST will exhibit greater improvements in physical activity, dietary patterns, medication adherence, and adherence to blood glucose monitoring compare to the education group.
Time Frame
Baseline to 12 months
Title
Accessing change in Diabetes self-management behavior via Use of home blood glucose monitoring
Description
Participants who receive DCST will exhibit greater improvements in adherence to blood glucose monitoring compare to the education group.
Time Frame
Baseline, 6 months and 12 months
Title
Improved glycemic control
Description
Participants who receive DCST will show greater improvements in HbA1c compared to the diabetes education alone.
Time Frame
Baseline, 6 months and 12 months
Title
Change in self-efficacy
Description
This contains 5 items that inquire about patients' certainty about degree of pain control, pain during daily activities, controlling pain during sleep, and making pain reductions without extra medication.
Time Frame
Baseline, 6 months and 12 months
Title
Change in Physical Activity
Description
Patient-reported physical activity will be assessed using the well-validated Community Healthy Activities Model Program for Seniors (CHAMPS). Participants who receive DCST will show improved self efficacy for managing symptoms and diabetes self-management compared to the diabetes education alone.
Time Frame
Baseline, 6 months and 12 months
Title
Assessing change in Physical Activity
Description
Wireless activity tracking devices will be used to assess daily steps and distance. Participants who receive DCST will show improved self efficacy for managing symptoms and diabetes self-management compared to the diabetes education alone.
Time Frame
Baseline, 6 months and 12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosis of Stage I to III breast cancer, diagnosis of diabetes mellitus type 2 completed local definitive treatment (i.e., surgical treatment, chemotherapy and/or radiation therapy), physician verification of ability to participate in the intervention, English speaking. Exclusion Criteria: <21 years of age, severe cognitive or hearing impairment, unable to provide meaningful consent (i.e., impairment such that descriptions of the research are not clearly understood), presence of a health problem that precludes safe participation in the intervention.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rebecca A Shelby, PhD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
32289471
Citation
Shelby RA, Dorfman CS, Arthur SS, Bosworth HB, Corsino L, Sutton L, Owen L, Erkanli A, Keefe F, Corbett C, Kimmick G. Improving health engagement and lifestyle management for breast cancer survivors with diabetes. Contemp Clin Trials. 2020 May;92:105998. doi: 10.1016/j.cct.2020.105998. Epub 2020 Apr 11.
Results Reference
derived

Learn more about this trial

I HEAL for Breast Cancer Survivors With Diabetes

We'll reach out to this number within 24 hrs